JH

Jauhar Habib Ansari

Active Director Director DIN 09681410
DIN 09681410 First appointment Jul 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value •••• Premium profile

About Jauhar Habib Ansari

Data last updated:

Jauhar Habib Ansari is a Director at Bioshaiz Private Limited (since 2022). The company operates in Pharma. Bioshaiz Private Limited reported revenue of ₹4.49 Cr (FY 2024).

DIN 09681410
Primary Designation Director
Industry Pharma
First Appointment 21 Jul 2022
Oldest Company Age 4 yrs
Largest company Bioshaiz Private Limited · ₹4.49 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bioshaiz Private Limited U24299OR2022PTC040323
Director21 Jul 20222022₹4.49 Cr (FY 2024)Active

Board colleagues of Jauhar Habib Ansari

NameDINCompanyDesignation
Nahid Sanobar09681409Bioshaiz Private LimitedDirector

Directorship timeline

Open interactive timeline →
Bioshaiz Private Limited
Premium access

Shareholding and investment profile for Jauhar Habib Ansari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jauhar Habib Ansari

Jauhar Habib Ansari currently holds 1 directorship: Bioshaiz Private Limited (Director, since 21 Jul 2022, revenue ₹4.49 Cr (FY 2024)).

Jauhar Habib Ansari was first appointed on 21 Jul 2022 as Director at Bioshaiz Private Limited.

The current boards of Jauhar Habib Ansari's companies include Nahid Sanobar (Bioshaiz Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available